|
- NEW! Economic impact of the preparation scenario for cytotoxic drugs: an observational study (European Journal of Hospital Pharmacy Practice, 2008)
- NEW! Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment (Annals of Occupational Hygiene, 2009)
- NEW! Contamination Comparison of Transfer Devices Intended for Handling Hazardous Drugs (Hospital Pharmacy, 2008)
- NEW! Intravesical Antineoplastic Therapy Following Transurethral Resection of Bladder Tumors: Nursing Implications From the Operation Room to Discharge (Clinical Journal of Oncology Nursing, 2007)
- NEW! Leakproof Connection Integrity Test For Devices Intended for Handling Hazardous Drugs. (Presented at ASHP Midyear Clinical Meeting, December, 2007)
- Evaluation of Vial Transfer Devices for Containment of Hazardous Drug Vapors. (Presented ASHP Midyear Clinical Meeting, 2007)
- Implementation of a safety device for use in preparing and administering cytotoxic medications in an inpatient setting (P360D). (ASHP Abstracts & Program Resources on CDROM. ASHP Midyear Clinical Meeting, December, 2006)
- Evaluation of operability of the PhaSeal System, a sealed handling device for anticancer agents (Japanese Journal of Pharmaceutical Health Care and Sciences, 2006)
- Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques (American Journal of Health-System Pharmacy, 2006)
- Practical implementation of a closed system (PhaSeal) for the preparation, administration and disposal of Cytotoxic drugs in a busy ambulatory cancer centre (J Oncol Pharm Practice, 2004)
- Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV preparation with a closed system (Hospital Pharmacy, 2003)
- Using a closed-system protective device to reduce personnel exposure to antineoplastic agents (American Journal of Health-System Pharmacy, 2003)
- Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an IV admixture area (American Journal of Health-System Pharmacy, 2002)
- Exposure to anti-cancer drugs during preparation and administration. Investigations of an open and a closed system (Journal of Environmental Monitoring, 2002)
- How to protect environment and employees against cytotoxic agents, the UZ Ghent experience (Journal of Oncology Pharmacy Practice, 2001)
- Implementation of safer chemotherapy systems utilized in the VA medical (ASHP, 2000)
- ASHP Guidelines on handling hazardous drugs. (Am J Health-Syst Pharm, 2006) Download publication
- Evaluation of the PhaSeal® hazardous drug containment system (Hospital Pharmacy, 1999)
- Investigations of leakage, spill, airborne emission and exposure during preparation and administration of cytotoxic drugs using different preparation techniques (National Institute for Working Life, 1999).
- Evaluation of technetium assay for monitoring of occupational exposure to cytotoxic drugs (J Oncol Pharm Practice, 1997)
|
